The competing risks illness-death model describes the dynamics of healthy subjects who may move to an "illness" state before entering into one of several competing terminal states. A motivating example concerns patients in a hospital who may acquire infections during their stay, where the competing terminal states are discharged alive and death in the hospital. We consider a cross-sectional sampling of independent competing risks illness-death processes in which data are subject to length bias and censoring and develop estimators for functionals of the underlying distribution such as the joint probability of the terminal state and illness (infection) and cumulative incidence functions. We apply the methodology to infection data obtained in a cross-sectional study of patients hospitalized in intensive care units.
INTRODUCTION
Nosocomial infections increase the mortality rate and prolong hospitalization time, hence are closely monitored. Prospective designs that estimate infection rates by following patients from entry into the hospital until discharge are expensive and time-consuming. Cross-sectional designs that sample patients who are available on a given day usually require fewer resources and are attractive alternatives. However, cross-sectional data tend to include patients who stay longer in the hospital and methods for correcting this selection bias are needed.
The framework considered here is that of the illness-death model, also known as the semi-competing risks model, in which subjects may visit an "illness" state before moving to the terminal state "death" (Keiding, 1991 (Keiding, , 2006 . When studying nosocomial infections, a subject enters the "illness" state when he acquires an infection, and enters the absorbing state "death" when he leaves the hospital. Mandel and Fluss (2009) develop estimators for the probability of acquiring a nosocomial infection using cross-sectional data. The current paper extends their method to a competing risks illness-death model as depicted in Figure 1 . The model describes the dynamics of a patient who enters the hospital without an infection (State H) and may acquire an infection (State I) before he is discharged alive from the hospital (State D1) or dies in the hospital (State D2). The aim is to estimate functionals of the above model under minimal
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There are numerous methods for dealing with cross-sectional sampling in survival analysis with (e.g. Vardi, 1989) and without (e.g. Wang, 1991) assumptions on the distribution of truncation times. Huang and Wang (1995) and Peng and Fine (2006) study truncated competing risks models, while Keiding (1991 Keiding ( , 2006 and Saarela and others (2009) study the illness-death model under left truncation. Here, we extend the work of Mandel and Fluss (2009) and study the competing risks illness-death model under left truncation, where data on the total hospitalization time and on the hospital mortality are available for all patients. Such data are easily and reliably obtained from the hospital registry.
In the sequel, we distinguish between quantities of the cross-sectional population to that of the general population by denoting the latter with asterisks. Let X * 0 and X * 1 denote, respectively, the sojourn times in States H and I in the general population, and let Y * = X * 0 + X * 1 denote the total lifetime. Let D * be an indicator denoting the terminal state, where D * = 1 (D * = 2) if the terminal state is D1 (D2). We denote by F * the trivariate distribution function of (X * 0 , Y * , D * ), and we assume that E(Y * ) < ∞. The goal is to estimate probabilities such as P(X * 1 > 0, D * = 2) and P(X * 0 t, X * 1 > 0) using cross-sectional data. The paper is organized as follows. Sections 2 and 3 provide estimators for measures of interest for a population in a steady state. Section 4 generalizes them to a nonparametric truncation model. Section 5 presents briefly the findings of a simulation study that is reported in the supplementary material available at Biostatistics online (http://www.biostatistics.oxfordjournals.org). Section 6 applies the methods to infection data from a cross-sectional study of patients in intensive care units (ICUs). Section 7 completes the paper with a short discussion.
ESTIMATION UNDER STEADY STATE
A cross-sectional sample contains all subjects who are in the hospital at a given time point t 0 . A patient whose total hospitalization time is 2 days, say, is more likely to be sampled than a patient whose hospitalization time is 1 day as he has twice the chance to be included in the sample. Thus, the longer the stay in the hospital, the higher the chance to be included. In order to make this observation formal, several assumptions regarding the dynamics of the population over time are needed. This section develops estimators under a steady state assumption, and Section 4 provides estimators under weaker assumptions.
292
M. MANDEL ASSUMPTION 2.1 Steady state. (i) Patients enter the hospital according to a homogeneous Poisson process, (ii) F * is independent of time, and (iii) patients are independent and are independent of the entrance process to the hospital. Assumption (i) is strong but is relaxed in Section 4. Assumption (ii) is reasonable as most patients stay in the hospital less than 1 month, and we do not expect to see significant changes in the distribution F * in such a short time. Assumption (iii) seems strong and problematic as one would expect a high rate of transmission of infections between patients. Grundmann and others (2005) conducted a large study to check the magnitude of patient-to-patient transmission of nosocomial infection in ICUs. Genotyping 10 bacterial species, they estimated that 14.5% of all acquired infections in ICUs could be associated with transmission between patients. This shows that dependence between patients does exist but is not very strong. The influence of dependence on our estimator is studied by simulation in Section 5 and in Section A of the supplementary material available at Biostatistics online.
The distribution of a patient in the cross-sectional population, F, depends on the distribution in the total population, F * , and on the sampling weights. Under steady state, the sampling weights are proportional to the total hospitalization time. Specifically (see Cox, 1969; van Es and others, 2000) 
where
, that is, the sojourn time in H, the total lifetime, and the terminal state in the cross-sectional population. Note that variables corresponding to sampled individuals have a different distribution than that of the general population, hence are denoted without an asterisk. Let T be the time of entering the hospital and Z = t 0 − T denote the time from entering the hospital to sampling (the truncation time), then the steady state implies that
Consider a fixed follow-up period of c time units from the sampling time onward, where c can be any nonnegative number including 0 (no follow-up) and ∞ (complete follow-up). The data are n independent realizations of (Z ,X 0 , , Y, D), whereX 0 = min(X 0 , Z + c) is the possibly censored sojourn time in State H and = I {X 0 < min(Y, Z + c)} is an indicator for observed infection. We assume that Y and D are available from the hospital registry, therefore, are observed for all individuals. However, the time and occurrence of infections for those who are not infected on or before the end of the follow-up are not observed, and hence, X 0 may be interval censored (X 0 X 0 Y for those noninfected at the end of the follow-up). The censoring mechanism is similar to the multiplicative censoring model of Vardi (1989) , with the additional information X 0 Y . By (2.1) and (2.2), the density for those who acquired an infection before the end of the follow-up, that is, = 1, is given by
, where a + = max(a, 0), we have
This distribution is a weighted version of F * (dx, dy, d) with sampling weights {y − (x − c) + }. Using the fact that {X * 1 > 0} = {X * 0 < Y * }, direct integration with respect to (2.4) gives
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Equations (2.5)-(2.7) suggest the following inverse weighting estimators for the parameters of interest:
for d = 1, 2. These estimators produce the 2 × 2 probability table of I {X * 1 > 0} and D * which can be used to derive measures of interest such as those mentioned above. An R code for estimating this table is given in the supplementary material available at Biostatistics online.
Although the model used so far has only 2 terminal states, the method and estimators are immediately extended to an arbitrary number of competing risks. In Section 6, we apply the method to data with 3 terminal events. Furthermore, by reversing the direction of the arrows in Figure 1 (interpreting H as an absorbing state of leaving the population), the variable D * may represent a covariate rather than a terminal state, and the estimators above provide measures for the association between the covariate and infection.
The estimators (2.8) and (2.9) are ratios of empirical averages, hence are strongly consistent and have an asymptotic normal distribution under mild conditions, similar to those given in Theorem 1 of Mandel and Fluss (2009) 
, where the components of EW are given in (2.5-2.7), and can be estimated by the empirical covariance matrix of W. A variance estimator for (P(X * 1 > 0, D * = 1),P(X * 1 > 0, D * = 2),P(D * = 1)) is readily obtained by the delta method.
Using the estimators (2.8) and (2.9), one can estimate other parameters of interest such as the conditional probability of death given an infection is acquired, P(D * = 2|X * 1 > 0), or the odds ratio of death between infected and noninfected patients
. REMARK 2.2 For a complete follow-up, c = ∞, the distribution F * can be estimated by inverse weighting: Vardi, 1985) , from which estimators for any functional are easily obtained. Similarly, for any c, the joint distribution function of Y * and D * can be obtained by inverse weighting. This, for example, was used to obtain (2.9).
REMARK 2.3 There is no guarantee that the estimator (2.8) is smaller than 1 or thatP(
However, since the estimators are consistent, these rarely occur in practice. In our simulation study, such peculiarities occurred in fewer than 0.1% of the sampled data sets.
TIME-DEPENDENT MEASURES
It is difficult to interpret the measures presented at the end of Section 2 because they mask the effect of time. For example, those patients who die during their first few days in the hospital have a shorter period of risk for acquiring infections compared to those who stay longer in the hospital. At that point, one may try to fit a model in which infection is a time-dependent risk factor for mortality. However, since infection is an internal covariate (Kalbfleisch and Prentice, 2002) , the interpretation may be difficult (Wolkewitz and others, 2008) . It is, therefore, customary to consider a multistate framework over the states "infection", "death in the hospital," and "discharge alive" (see Figure 1) and to estimate the cause-specific hazard or the cumulative incidence function for each transition (Putter and others, 2007) .
Let X * 0 be the time until the occurrence of the first of acquiring an infection, death in the hospital, or discharge alive, that is, the time in State H. The events of interest are {H → I} = {X * 0 < Y * }, infection acquired in the hospital, {H → D1} = {X * 0 = Y * } ∩ {D * = 1}, discharge alive without infection, and {H → D2} = {X * 0 = Y * } ∩ {D * = 2}, death without infection (see Figure 1) . In competing risks settings, one is usually interested in the cumulative incidence functions or in the cause-specific hazard functions defined as
where A is one of {H → I}, {H → D1}, and {H → D2} (e.g. Putter and others, 2007) . Since
} that expresses the cause-specific hazard in terms of the cumulative incidence functions.
In our setting, for {H → I}, we have
and for {H → D j}, we use
These equalities follow from the same inverse weighting reasoning used in Section 2 with the additional time-dependent indicator I {Y t}. As in Section 2, estimators are obtained using (2.6) and empirical averages.
The estimators are based on differences, hence may result in negative values. For large samples, this problem disappears since the estimators are all consistent. In small samples, one can use the naive approach and replace negative estimates with 0. This approach is taken here for the calculation of the cumulative incidence functions in Section 6.
To estimate the cumulative incidence functions of discharge alive and death in the hospital for those infected, that is, the transitions I→D1 and I→D2 of Figure 1 , note that The competing risks illness-death model 295 which together with (2.5) suggest the estimator
This is a weighted estimator calculated by the subsample of those who have been found infected. Often, interest lies on the probability
, where the time is measured from infection rather than from admission to the hospital. An estimator for this parameter is given bŷ
In fact, any functional of the distribution of (X * 1 , Y * , D * )|X * 1 > 0 can be obtained by a similar weighted average with weights i /{Y i − (X 0i − c) + }. However, the number of observations that contribute to the estimator is usually small (only those infected before the end of their follow-up), hence, such an estimator is expected to have a large variance.
RELAXING THE STEADY STATE ASSUMPTION
This section relaxes the steady state assumption and develops estimators under the framework of truncation models (Woodroofe, 1985; Wang and others, 1986) . Here, the gap time between entering the hospital and sampling, Z * , follows an unspecified probability law G and it is independent of (X * 0 , Y * , D * ) ∼ F * . Data are restricted to subjects who satisfy Z * Y * . The steady state assumption gives rise to the uniform truncation model in which Z * has a uniform distribution; see (2.2). The model is similar to relaxing Assumption (2.1) (i) by assuming that entrances are according to an inhomogeneous Poisson process with an unknown rate function (see Kalbfleisch and Lawless, 1989; Mandel, 2007) .
As before, the sample consists of realizations of (Z ,X 0 , , Y, D), whereX 0 = min(X 0 , Z + c), = I {X 0 < min(Y, Z + c)}, and variables without an asterisk are conditional on the event {Z * Y * }. In order to avoid technical problems of identifiability, we assume that G(y min ) > 0, where y min is the smallest value in the support of Y * , and that G(y) − G(x − c) > 0 for x < y on the support of F * . We also assume that E{1/G(Y * )} < ∞ which is needed for asymptotic properties of our estimators.
Under the truncation model, we have
and after integrating z out
As in (2.4), the likelihood is a weighted version of F * , hence
The marginal density of
For estimation, we replace the expectations (4.2)-(4.4) by empirical averages, exactly as is done in Section 2. Typically, however, G is unknown and should be replaced by an estimator. A natural choice is the product-limit estimator,Ĝ PL , based on the truncated data (Z i , Y i ) (Woodroofe, 1985; Wang and others, 1986 ). An R code for calculating the estimate is given in the supplementary material available at Biostatistics online.
Estimation of time-dependent measures, as those presented in Section 3, is done in a similar and a straightforward way. Asymptotic properties of the estimators can be established as in Mandel and Fluss (2009) . However, since the expressions for the variances are complicated, we suggest to estimate the variance using bootstrap methods for truncated data (Gross and Lai, 1996) . REMARK 4.1 The truncation model with G uniform reduces to the model studied in Section 2. Thus, the truncation model uses fewer assumptions than the estimators presented in previous sections, and, hence, is more robust. However, the estimator has its drawbacks. It is less efficient when the steady state assumption holds (Wang, 1989; Mandel, 2007) and is not always applicable as the product-limit estimator may not exist (Wang and others, 1986) . A compromise between a completely unspecified and a completely specified model for G may be worth looking at in specific cases. Possible models are parametric models (Wang, 1989) and models with shape constraints on G, such as an increasing failure rate (Tsai, 1988) .
SIMULATION
A simulation study was conducted in order to examine the performance of the estimators under various scenarios. The full simulation study is given in Section A of the supplementary material available at Biostatistics online. Here, we summarize the most important findings.
The estimators with (Section 2) and without (Section 4) the steady state assumption have similar bias and variance when the steady state assumption holds and both perform very well. This is somewhat surprising as simulation studies for similar models showed better performance of the former estimator under steady state (Mandel, 2007; Mandel and Fluss, 2009) . When the truncation distribution is not uniform (entrance process is inhomogeneous Poisson), the estimator based on truncation models continues to perform well, but the estimator that uses the steady state assumption is biased. Dependence among subjects may cause bias, especially for the estimator that uses the steady state assumption.
BLOODSTREAM INFECTIONS IN ICUS
We have analyzed infection data that were collected on critically ill patients in 5 hospitals in Israel from the first day of deterioration until discharge or 30 days others, 2005, 2008) . For the current analysis, we consider only those patients who, on the sampling day, were hospitalized in ICUs for fewer than 30 days. We focus on bloodstream infections (BSIs)-a severe infection that is usually treated in ICUs and is one of the main causes of death in hospitals (Martin and others, 2003) . Because the follow-up length depends on the day of deterioration, and hence on Z , while our method requires that it will be independent of Z , we consider only infections that were acquired before the sampling day, that is, c = 0. In Section B of the supplementary material available at Biostatistics online, we reanalyze the data considering all infections, including those that were acquired after the sampling day, and obtain similar results.
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In our data,X 0 is the time from admission to the ICU until acquiring a BSI or until sampling, whichever occurs first, and Y is the time until the first of discharge alive (D = 1), death in the the ICU (D = 2), or long stay (more than 30 days; D = 3). We distinguish here between subjects who acquired a BSI in the ICU, S = 1, and subjects who were admitted to the ICU with an active BSI, S = 2; we denote by S = 0 those who neither acquired a BSI in the ICU nor had an active BSI on admission. Table 1 summarizes the data. There are n = 153 patients, with a total of 48 (31.4%) BSI cases; among them 29 patients acquired a BSI in the ICU before the sampling day and 19 were admitted to the ICU with an active BSI. The data are of a prevalence population, hence, underrepresent patients who stayed in the ICU for only a few days. Next, we will correct the selection bias using the methods described in the previous sections. Table 2 presents estimates for the joint probability function of BSI status, S * , and the terminal outcome, D * . To facilitate estimation, we defined = 0 for those subjects who had an active BSI on admission (i.e. S = 2), and estimated the joint probability of {S * = 1, D * = d} by (2.8). There are 2 equivalent ways to estimate the probability of {S * = 2, D * = d}. The first defines a dichotomous variable, S2d i , by S2d i = 1 if S i = 2 and D i = d and otherwise S2d i = 0, and estimates {S * = 2, D * = d} by (2.9) with the new variables S2d i replacing D i . The second redefines = 1 for those subjects with S = 2 and estimates by (2.8), the probability of {S * = 2, D * = d} ∪ {S * = 1, D * = d} from which the desired probability is extracted. To complete the table, estimates for the probabilities of the terminal events were obtained by (2.9). The table shows estimates that do (part A) and do not (part B) rely on the steady state assumption, with standard errors estimated using the delta method and the bootstrap with 200 replications, respectively. The estimates are quite close, indicating a population in a steady state (this assumption is discussed further in Section 6.4).
Time-independent measures
The differences between Tables 1 and 2 are due to the biased sampling and to the missing information on infections acquired after sampling. The length bias is best demonstrated by the probability of staying more than 30 days in the ICU that is reduced from 18% in the data to an estimate of only 5-6%. Figure 2 depicts the empirical survival function of the total length of stay in the ICU and the nonparametric maximum likelihood estimate under the steady state assumption (Vardi, 1989) . As expected, the empirical function that estimates length of stay in a prevalence population is stochastically larger than the corresponding estimate of the incidence population. The estimated median length of stay in the prevalence population is 12 days compared to an estimate of 5 days in the general population. The corresponding estimates of the mean length of stay are 15 and 8 days.
About 60% of the ICU patients are discharged alive from the ICU before Day 30 without acquiring a BSI (either before or during their stay in the ICU; see Table 2 ). The probability of acquiring a BSI during hospitalization in the ICU is about 20%. The conditional probabilities of dying in the ICU and of staying there longer than 30 days for those acquiring a BSI in the ICU (0.49 and 0.17) are much larger than the corresponding probabilities for those who do not acquire a BSI (0.08 and 0.02). This demonstrates the large association between BSIs and morbidity and mortality. However, this does not allow for a causal interpretation because a BSI may be a surrogate for patients' characteristics that directly cause death. Notably, the corresponding estimates for those who enter the ICU with an active BSI are 0.15 and 0.08 and are much smaller than those of patients who acquire BSIs in the ICU. A possible explanation is that for the former BSI may be the main reason for hospitalization in the ICU while for the latter, a BSI is an additional complication.
Time-dependent analysis
This subsection considers estimation of functionals in a multistate framework, as discussed in Section 3. Specifically, it looks at BSI, discharged alive and death as competing risks and estimates the cause-specific
The competing risks illness-death model hazard and the cumulative incidence function for each. The transitions from BSI to the terminal states are not estimated because the number of patients acquiring a BSI in the ICU is too small (29, see Table 1 ). The current analysis excludes those who were admitted to the ICU with an active BSI, so that all patients are in State H at time 0 (Figure 1) . Figure 3 depicts estimates for the cumulative incidence functions of the 3 competing risks and for the cause-specific hazard functions. The latter were obtained by a Gaussian kernel smoother with bandwidth equals to 3. The steep increase of the cumulative incidence function of discharged alive during the first 10 days shows that the hospitalization time in the ICU is relatively short (also see Figure 2 ). The causespecific hazard of acquiring a BSI is stable over the first 2 weeks and then decreases. The cause-specific hazard of mortality shows an opposite trend with a low probability of mortality during the first days. This pattern agrees well with the findings of others (2004, 2007) of a beneficial effect of the ICU on mortality for the first 3 days and of no significant effect from Day 4 onward.
Covariates
The association between a baseline risk factor and infection can be estimated by replacing the terminal state D with the risk factor in (2.8) and (2.9). Here, we consider the association between the presence of an infection other than a BSI on admission to the ICU and a nosocomial BSI. The non-BSI types include pneumonia, urinary tract infection, surgical wound infection, and other infections; see Mnatzaganian and others (2005) , for more details. Patients who had an active BSI on admission were excluded from the analysis.
Fifty two patients out of 134 had a non-BSI on admission; of those 10 (19.2%) acquired a BSI in the ICU. From the 82 patients who did not have an infection on admission, 19 (23%) acquired a BSI during their stay in the ICU.
Under the steady state assumption, the estimated probabilities of acquiring a BSI in the ICU for those who had, and for those who did not have, a non-BSI on admission are 0.161 and 0.236, respectively. This suggests that having a non-BSI on admission is a protective factor. However, a formal test, based on the asymptotic normal distribution of the estimators, reveals that the probabilities are not significantly different (P-value 0.54). Still, the result is surprising and inconsistent with the multivariate model of Mnatzaganian and others (2005) in which an active infection on entry was found as a significant risk factor for a nosocomial BSI. One possible explanation is that the population and the outcome of Mnatzaganian and others somewhat differ from the ones considered in the current analysis; for example, BSIs acquired after being discharged from the ICU are not included in our analysis, while Mnatzaganian and others do include them. A second possible explanation is that antibiotic treatment given for the non-BSIs reduces the probability of acquiring a BSI.
To further explore the influence of a non-BSI on a BSI, we conducted a competing risks analysis, stratifying by non-BSI on admission. Because of the small numbers, we combine the terminal states discharged alive and death to a single state and analyze a model with 2 competing risks: discharged (alive or dead) and BSI. Figure 4 presents the estimated cumulative incidence functions of the 2 competing risks; the right panel presents the estimates for those admitted to the ICU with a non-BSI, and the left panel depicts the estimates for those admitted without any infection. The cumulative incidence functions of a BSI and of discharge for those admitted with an infection are both larger in the first few days than the corresponding functions for those admitted without an infection. This suggests that the probability of acquiring a BSI is greater at first for those admitted with a non-BSI, but then the functions cross; after 4 days for a BSI and after 10 days for discharge.
Last, the influence of a non-BSI on admission on the terminal outcome, discharge alive, or death can be assessed by estimating their joint probability table using the total length of stay as weights (see Remark 1). The estimated probabilities of death for those who had a non-BSI on admission and for those who did not are, respectively, 0.242 (standard error = 0.073) and 0.125 (standard error = 0.037). The respective mean lengths of stay in the ICU are 8.6 (standard error = 0.91) and 7.6 (standard error = 0.78). Thus, patients who are infected on admission are expected to stay longer in the ICU and are at a greater risk of dying in the ICU.
Testing the steady state assumption
As mentioned in Section 4, the steady state assumption corresponds to a truncation model with G uniform. Estimators under this model are more efficient than those discussed in Section 4 when the model is adequate but are not robust to model misspecification (Huang and Wang, 1995; Mandel, 2007) . Various tests for the uniform assumption based on truncation data are studied by Mandel and Betensky (2007) . We have conducted 2 formal tests: a Wilcoxon signed rank test that compares the distribution of the backward and forward residual lifetimes, and a 1-sample Kolmogorov-Smirnov test that compares the empirical distribution function of Z /Y to the U (0, 1) distribution. Neither of the tests rejected the steady state assumption with a significant level of 5% (P-values 0.107 and 0.128). In addition, we conducted a graphical test suggested by Wang (1991) that plotted the product-limit estimate of G and compared it to the uniform distribution; see Figure 5 . Both the formal tests and the graphical test suggest that the steady state assumption is reasonable.
DISCUSSION
We have presented a method for deriving consistent and simple estimators for various epidemiological measures using prevalence designs. The estimators are based on several important assumptions that should not be taken for granted. The steady state assumption can be partially tested as discussed in Section 6.4 and can be relaxed when there are enough observations for a valid estimation of G (see Section 4). The assumptions that the rate of infection is constant over calendar time and that patients are independent are more difficult to assess and their influence on the inference of cross-sectional as well as prospective designs should be further explored.
A second assumption used here concerns complete information on the length of stay in the hospital and on the terminal state. In many cases, such data can be reliably collected from the hospital registry. When such data are unavailable, methods for censored data, similar to those discussed by Keiding (1991 Keiding ( , 2006 and by Saarela and others (2009) for the illness-death model, should be employed.
A third, and seemingly the most problematic, assumption concerns availability of data on infections that were acquired before the sampling day. Such data are usually collected from patients' files and may be subject to measurement errors and missing records, especially for patients with long hospitalization times. In such cases, sensitivity analysis can help in understanding the magnitude of the problem. A preliminary study of this issue revealed that the estimators are not sensitive to missing infection information. The reason is that missing information is mostly for patients whose Z values (and hence Y values) are large. Our estimators are of an inverse weighting type, and the contribution of individuals with long hospitalization time is relatively small.
The ICU data suggest that BSIs increase mortality rate and prolong hospitalization time. To better understand their effect, a multistate model should be fitted in which the cause-specific hazard of death for those who acquired a BSI is compared to the corresponding hazard of those who did not acquire a BSI. Such causal analysis should take into account the time elapsed from admission to the ICU and from acquiring a BSI, and possibly incorporates risk factors. This necessitates imposing additional assumptions and fitting semiparametric or parametric models, and it is left for future research.
SUPPLEMENTARY MATERIAL
Supplementary material is available at http://biostatistics.oxfordjournals.org.
